High mpox mortality in people living with HIV and immune suppression: Lessons from Sierra Leone for integrated outbreak preparedness and response
Journal of Interventional Epidemiology and Public Health·
- DOI
- 10.37432/jieph-d-26-00257
- PMID
- —
- PMCID
- —
- OpenAlex
- —
- Study type
- Cohort study
- Publisher
- African Field Epidemiology Network
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The piece argues for integrated HIV/STI and mpox prevention and care, pre-exposure vaccination of at-risk people, continued investment in surveillance and data systems, and pre-approved emergency research protocols as part of outbreak preparedness, with a long-term aim beyond acute response.
Structured evidence summary
Research question
The commentary frames a national cohort study from the 2025 mpox outbreak in Sierra Leone, emphasizing how integrated data systems can identify people living with advanced HIV as a high-risk group and shape outbreak response.
Study design
The underlying work referenced is described as a national cohort study; the supplied record itself is a peer-reviewed journal article (commentary/editorial framing) rather than a primary dataset.
Population and setting
The setting is the 2025 mpox outbreak in Sierra Leone, with the focus population being people living with HIV, particularly those with advanced HIV infection.
Main findings
The abstract reports that people with advanced HIV faced markedly elevated mpox mortality during the 2025 Sierra Leone outbreak, and that about 90% of confirmed mpox cases were linked to HIV status using a national unique health identifier. It also notes the cohort demonstrates how routinely collected health service data can be applied during outbreaks to identify vulnerable groups and guide interventions.
Public-health relevance
The piece argues for integrated HIV/STI and mpox prevention and care, pre-exposure vaccination of at-risk people, continued investment in surveillance and data systems, and pre-approved emergency research protocols as part of outbreak preparedness, with a long-term aim beyond acute response.
Important limitations
Only an author-reported national cohort study from Sierra Leone is described, with no details on sample size, HIV disease staging criteria, treatment access, or cause-of-death ascertainment. The supplied record is a single article abstract/metadata; decision-grade interpretation would require the original paper.
GIDS interpretation
In discoverability terms, the article sits within outbreak-investigation, surveillance, and vaccination literatures on mpox in Sierra Leone, and may help contextualize future signal triage by highlighting integrated HIV/mpox data linkages as a potential data source; the supplied evidence does not by itself confirm any active surveillance signal.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 11 auditable classifier relationships to diseases, places, topics, and study design.